Edward J. Brnardic

453 total citations
6 papers, 162 citations indexed

About

Edward J. Brnardic is a scholar working on Sensory Systems, Biochemistry and Complementary and alternative medicine. According to data from OpenAlex, Edward J. Brnardic has authored 6 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Sensory Systems, 4 papers in Biochemistry and 2 papers in Complementary and alternative medicine. Recurrent topics in Edward J. Brnardic's work include Phytochemicals and Antioxidant Activities (4 papers), Ion Channels and Receptors (4 papers) and Herbal Medicine Research Studies (2 papers). Edward J. Brnardic is often cited by papers focused on Phytochemicals and Antioxidant Activities (4 papers), Ion Channels and Receptors (4 papers) and Herbal Medicine Research Studies (2 papers). Edward J. Brnardic collaborates with scholars based in United States, United Kingdom and Poland. Edward J. Brnardic's co-authors include David J. Behm, Brian G. Lawhorn, R. M. Garbaccio, Brian C. Magliaro, Marlene A. Jacobson, Yuhsin Kuo, Pete H. Hutson, George D. Hartman, Mark E. Fraley and Julie A. O’Brien and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Expert Opinion on Therapeutic Patents.

In The Last Decade

Edward J. Brnardic

6 papers receiving 156 citations

Peers

Countries citing papers authored by Edward J. Brnardic

Since Specialization

Citations

This map shows the geographic impact of Edward J. Brnardic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Brnardic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Brnardic more than expected).

Fields of papers citing papers by Edward J. Brnardic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Brnardic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Brnardic. The network helps show where Edward J. Brnardic may publish in the future.

Co-authorship network of co-authors of Edward J. Brnardic

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Brnardic. A scholar is included among the top collaborators of Edward J. Brnardic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Brnardic. Edward J. Brnardic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	TRPV4 antagonists: a patent review (2015–2020) 2021 ·Expert Opinion on Therapeutic Patents ·Brian G. Lawhorn, Edward J. Brnardic, David J. Behm	33
2	Recent advances in TRPV4 agonists and antagonists 2020 ·Bioorganic & Medicinal Chemistry Letters ·Brian G. Lawhorn, Edward J. Brnardic, David J. Behm	46
3	Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4) 2019 ·Journal of Medicinal Chemistry ·(unknown), (unknown), David J. Behm, Edward J. Brnardic, Melissa H. Costell, Dennis A. Holt, Larry J. Jolivette, Jay M. Matthews, (unknown), (unknown), Jaclyn R. Patterson, (unknown), Ralph A. Rivero, Theresa J. Roethke, (unknown), (unknown), Lamont R. Terrell, Brian G. Lawhorn	19
4	Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4) 2018 ·Journal of Medicinal Chemistry ·Edward J. Brnardic, Guosen Ye, (unknown), Carla A. Donatelli, (unknown), J. Jeffrey McAtee, (unknown), Arthur Y. L. Shu, Karl F. Erhard, Lamont R. Terrell, (unknown), Yanan He, Melissa H. Costell, David J. Behm, Theresa J. Roethke, Patrick Stoy, Dennis A. Holt, Brian G. Lawhorn	20
5	3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts 2010 ·Bioorganic & Medicinal Chemistry Letters ·Edward J. Brnardic, Mark E. Fraley, R. M. Garbaccio, M. E. Layton, John M. Sanders, Chris Culberson, Marlene A. Jacobson, Brian C. Magliaro, Pete H. Hutson, Julie A. O’Brien, Sarah L. Huszar, Jason M. Uslaner, Kerry L. Fillgrove, Cuyue Tang, Yuhsin Kuo, (unknown), George D. Hartman	30
6	Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor 2010 ·ACS Medicinal Chemistry Letters ·R. M. Garbaccio, Edward J. Brnardic, Mark E. Fraley, George D. Hartman, Pete H. Hutson, Julie A. O’Brien, Brian C. Magliaro, Jason M. Uslaner, Sarah L. Huszar, Kerry L. Fillgrove, James H. Small, Cuyue Tang, Yuhsin Kuo, Marlene A. Jacobson	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact